The University of Southampton
University of Southampton Institutional Repository

Quantifying the intragenic distribution of human disease mutations

Quantifying the intragenic distribution of human disease mutations
Quantifying the intragenic distribution of human disease mutations
A wide variety of functional domains exist within human genes. Since different domains vary in their roles regarding overall gene function, the ability for a mutation in a gene region to produce disease varies among domains. We tested two hypotheses regarding distributions of mutations among functional domains by using (1) sets of single nucleotide disease mutations for six genes (CFTR, TSC2, G6PD, PAX6, RS1, and PAH) and (2) sets of polymorphic replacement and silent mutations found in two genes (CFTR and TSC2). First, we tested the null hypothesis that sets of mutations are uniformly distributed among functional domains within genes. Second, we tested the null hypothesis that disease mutations are distributed among gene regions according to expectations derived from the distribution of evolutionary conserved and variable amino acid sites throughout each gene. In contrast to the mainly uniform distribution of sets of silent and polymorphic mutations, sets of disease mutations generally rejected the null hypotheses of both uniform and evolutionary-influenced distributions. Although the disease mutation data showed a better agreement with the evolutionary-derived expectations, disease mutations were found to be statistically overabundant in conserved domains, and under-represented in variable regions, even after accounting for amino acid site variability of domains over long-term evolutionary history. This finding suggests that there is a non-additive influence of amino acid site conservation on the observed intragenic distribution of disease mutations, and underscores the importance of understanding the patterns of neutral amino acid substitutions permitted in a gene over long-term evolutionary history.
0003-4800
567-579
Miller, M.P.
42e6bccd-7d5f-42e3-852a-ad319bd8f6f7
Parker, J.D.
34055903-007a-42d0-b1af-2717f217ab41
Rissing, S.W.
c558b6cc-3131-4b58-a553-079648dbf2a5
Kumar, S.
5cb24a9c-a32b-4afc-8048-6d7517d1a7a0
Miller, M.P.
42e6bccd-7d5f-42e3-852a-ad319bd8f6f7
Parker, J.D.
34055903-007a-42d0-b1af-2717f217ab41
Rissing, S.W.
c558b6cc-3131-4b58-a553-079648dbf2a5
Kumar, S.
5cb24a9c-a32b-4afc-8048-6d7517d1a7a0

Miller, M.P., Parker, J.D., Rissing, S.W. and Kumar, S. (2003) Quantifying the intragenic distribution of human disease mutations. Annals of Human Genetics, 67 (6), 567-579. (doi:10.1046/j.1529-8817.2003.00072.x).

Record type: Article

Abstract

A wide variety of functional domains exist within human genes. Since different domains vary in their roles regarding overall gene function, the ability for a mutation in a gene region to produce disease varies among domains. We tested two hypotheses regarding distributions of mutations among functional domains by using (1) sets of single nucleotide disease mutations for six genes (CFTR, TSC2, G6PD, PAX6, RS1, and PAH) and (2) sets of polymorphic replacement and silent mutations found in two genes (CFTR and TSC2). First, we tested the null hypothesis that sets of mutations are uniformly distributed among functional domains within genes. Second, we tested the null hypothesis that disease mutations are distributed among gene regions according to expectations derived from the distribution of evolutionary conserved and variable amino acid sites throughout each gene. In contrast to the mainly uniform distribution of sets of silent and polymorphic mutations, sets of disease mutations generally rejected the null hypotheses of both uniform and evolutionary-influenced distributions. Although the disease mutation data showed a better agreement with the evolutionary-derived expectations, disease mutations were found to be statistically overabundant in conserved domains, and under-represented in variable regions, even after accounting for amino acid site variability of domains over long-term evolutionary history. This finding suggests that there is a non-additive influence of amino acid site conservation on the observed intragenic distribution of disease mutations, and underscores the importance of understanding the patterns of neutral amino acid substitutions permitted in a gene over long-term evolutionary history.

This record has no associated files available for download.

More information

Published date: 1 November 2003

Identifiers

Local EPrints ID: 56279
URI: http://eprints.soton.ac.uk/id/eprint/56279
ISSN: 0003-4800
PURE UUID: 24395c45-0196-4b95-aa40-ae0831d8aa73

Catalogue record

Date deposited: 06 Aug 2008
Last modified: 15 Mar 2024 11:00

Export record

Altmetrics

Contributors

Author: M.P. Miller
Author: J.D. Parker
Author: S.W. Rissing
Author: S. Kumar

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×